- Filed
- May 15, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 15, 2026 | 431.14M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 416.41M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 411.01M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $39K |
| Capex | Q1 2026 · Mar 31, 2025 | $0 |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $29.62M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$2.36M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $31.75M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $6.08M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $31.75M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $6.08M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $32.45M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $2.93M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $55.53M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $29.47M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.02 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | −$0.01 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.02 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | −$0.01 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $959K |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $1.41M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$6.39M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$2.32M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$135K |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$1.44M |